My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 335

    1.

    Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force.

    Hayden M, Pignone M, Phillips C, Mulrow C.

    Ann Intern Med. 2002 Jan 15;136(2):161-72.PMID: 11790072 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force.

    Wolff T, Miller T, Ko S.

    Ann Intern Med. 2009 Mar 17;150(6):405-10. Review.PMID: 19293073 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials.

    Sanmuganathan PS, Ghahramani P, Jackson PR, Wallis EJ, Ramsay LE.

    Heart. 2001 Mar;85(3):265-71.PMID: 11179262 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials.

    Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL.

    JAMA. 2006 Jan 18;295(3):306-13. Erratum in: JAMA. 2006 May 3;295(17):2002. PMID: 16418466 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.

    Morimoto T, Fukui T, Lee TH, Matsui K.

    Am J Med. 2004 Oct 1;117(7):459-68. Review.PMID: 15464702 [PubMed - indexed for MEDLINE]Related articles

    6.

    Aspirin for the primary prevention of cardiovascular events: recommendation and rationale.

    U.S. Preventive Services Task Force.

    Ann Intern Med. 2002 Jan 15;136(2):157-60.PMID: 11790071 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit.

    Rothberg MB, Celestin C, Fiore LD, Lawler E, Cook JR.

    Ann Intern Med. 2005 Aug 16;143(4):241-50.PMID: 16103468 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.

    Vrecer M, Turk S, Drinovec J, Mrhar A.

    Int J Clin Pharmacol Ther. 2003 Dec;41(12):567-77.PMID: 14692706 [PubMed - indexed for MEDLINE]Related articles

    9.

    Summaries for patients. Aspirin for the prevention of heart attacks in people without previous cardiovascular events: recommendations from the United States Preventive Services Task Force.

    [No authors listed]

    Ann Intern Med. 2002 Jan 15;136(2):I55. No abstract available. PMID: 11928737 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis.

    Pignone M, Earnshaw S, Tice JA, Pletcher MJ.

    Ann Intern Med. 2006 Mar 7;144(5):326-36.PMID: 16520473 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease.

    Keller TT, Squizzato A, Middeldorp S.

    Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005158. Review.PMID: 17636787 [PubMed - indexed for MEDLINE]Related articles

    12.

    Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.

    Antithrombotic Trialists' (ATT) Collaboration, Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A.

    Lancet. 2009 May 30;373(9678):1849-60.PMID: 19482214 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.

    De Schryver EL, Algra A, van Gijn J.

    Cochrane Database Syst Rev. 2003;(1):CD001820. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD001820. PMID: 12535415 [PubMed - indexed for MEDLINE]Related articles

    14.

    Update on aspirin in the treatment and prevention of cardiovascular disease.

    Hennekens CH.

    Am J Manag Care. 2002 Dec;8(22 Suppl):S691-700. Review.PMID: 12512736 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.

    Jones L, Griffin S, Palmer S, Main C, Orton V, Sculpher M, Sudlow C, Henderson R, Hawkins N, Riemsma R.

    Health Technol Assess. 2004 Oct;8(38):iii-iv, 1-196. Review.PMID: 15461876 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial.

    Hunt D, Young P, Simes J, Hague W, Mann S, Owensby D, Lane G, Tonkin A.

    Ann Intern Med. 2001 May 15;134(10):931-40.PMID: 11352694 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials.

    Berger JS, Krantz MJ, Kittelson JM, Hiatt WR.

    JAMA. 2009 May 13;301(18):1909-19.PMID: 19436018 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial.

    Ogawa H, Nakayama M, Morimoto T, Uemura S, Kanauchi M, Doi N, Jinnouchi H, Sugiyama S, Saito Y; Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Investigators.

    JAMA. 2008 Nov 12;300(18):2134-41. Epub 2008 Nov 9. Erratum in: JAMA. 2009 May 13;301(18):1882. PMID: 18997198 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Antiplatelet therapy and anticoagulation in patients with hypertension.

    Griffin G.

    Am Fam Physician. 2005 Mar 1;71(5):897-9. Review.PMID: 15768617 [PubMed - indexed for MEDLINE]Related articles

    20.

    The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force.

    Dubé C, Rostom A, Lewin G, Tsertsvadze A, Barrowman N, Code C, Sampson M, Moher D; U.S. Preventive Services Task Force.

    Ann Intern Med. 2007 Mar 6;146(5):365-75. Review.PMID: 17339622 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity